ICON Public Limited Company (ICLR)
Free
No email, no account, no signup.
Pulling latest news for ICON Public Limited Company…
Bull
Bear
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report –
Order analysis – $4.99 $1.25
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Sector
Clinical research services
Market Cap
$8.6B
Market sentiment
Sentiment has improved from a crisis/non-reliance narrative to cautious relief after the investigation conclusion and new guidance, but remains mixed due to restatement needs, control weaknesses, and reporting/compliance uncertainty.
Why NEUTRAL ?
While the investigation conclusion reduces one overhang and the market has repriced accordingly, confirmed material weaknesses, pending restatements, and Nasdaq compliance/reporting risk warrant a reassessment before moving to a clear add/reduce stance. Key watch items are the restatement timeline, remediation progress, and delivery versus 2026 guidance.
- Wait/review: hold only if you can tolerate elevated governance and reporting risk; consider delaying new buys until restatement and internal-control remediation visibility improves.
We're already tracking ICON Public Limited Company — here are the latest events we've registered
Recent News
- On May 27, 2026, ICON released Q4/FY 2025 results and disclosed the outcome of the Audit Committee investigation: clinical services revenue was overstated across Q3 2023–Q4 2024, and the company identified material weaknesses in internal control over financial reporting with a remediation plan underway. ICON also issued 2026 guidance (revenue ~$7.85–$8.15B and adjusted EPS ~$10–$11), received a Nasdaq notice related to a late 20-F filing, and the stock reacted positively after the investigation concluded. ICON also expanded US early-phase capacity (new San Antonio CRU with satellite sites).
Want to know how this news affects ICON Public Limited Company? Order the analysis.
Order analysis – Catalysts
Restatements for 2023–2024
Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Sources: news, filings, market data, and investor forums
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of ICON Public Limited Company will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.